Side Effects of Ilumya: An Overview and Guidance on Management
Ilumya, a brand-name medication, is an IL-23 inhibitor used to treat moderate-to-severe plaque psoriasis in certain adults. While it has proven effective in managing conditions like plaque psoriasis and psoriatic arthritis, it's essential to be aware of its potential side effects.
Common side effects of Ilumya include upper respiratory infections, injection site reactions, and diarrhea. Diarrhea may occur with Ilumya and was one of the most common side effects in clinical trials. If you experience diarrhea from Ilumya, it's important to stay hydrated and discuss the issue with your doctor.
Beyond these common side effects, less common adverse effects reported in clinical contexts for IL-23 inhibitors like Ilumya may include headache, fatigue, nausea, and transient liver enzyme elevations or infections beyond the upper respiratory tract. However, it's crucial to note that these are inferred from the known class effects of IL-23 inhibitors rather than explicitly stated in the current search data.
It's worth mentioning that Ilumya was not reported to cause hair loss in clinical trials. However, psoriasis affecting the scalp can cause temporary or permanent hair loss. If you have questions about hair loss and Ilumya, it's best to discuss them with your doctor.
Serious infections, such as pneumonia, were rare in clinical trials of Ilumya. Mild infections, including upper respiratory infections, were more common in people who received Ilumya. To prevent infection, eat healthily, exercise regularly, get a good night's sleep, and make sure your vaccines are up to date.
In case of a serious allergic reaction to Ilumya, call 911 or your local emergency number immediately. If injection site reactions occur with each injection or are very bothersome, it's important to discuss them with your doctor.
For a complete and authoritative list of less common side effects, consult the official Ilumya prescribing information from the FDA or the drug's label available on regulatory or manufacturer websites. These resources include full safety and adverse reaction profiles as established through clinical trials.
If side effects from Ilumya become bothersome or severe, talk with your doctor or pharmacist. Before taking Ilumya, discuss your health history with your doctor, including active infections, previous TB diagnosis, live vaccines, previous allergic reactions, pregnancy, breastfeeding, alcohol consumption, and more.
Ilumya does not have a known link to cancer, unlike some biologic medications used to treat psoriasis. However, serious side effects of Ilumya may include serious infection and allergic reaction. Symptoms of serious infection include weight loss, difficulty breathing, coughing, fever or chills, muscle aches, and blood in mucus.
In summary, while Ilumya is an effective treatment option for moderate-to-severe plaque psoriasis, it's crucial to be aware of its potential side effects. Common side effects include upper respiratory infection, injection site reactions, and diarrhea. Less common side effects, such as headache, fatigue, nausea, and transient liver enzyme elevations or infections beyond the upper respiratory tract, are inferred from the known class effects of IL-23 inhibitors. For a complete list of side effects, consult the official Ilumya prescribing information. If you experience any side effects that are bothersome or severe, discuss them with your doctor or pharmacist.
- While using Ilumya for medical-conditions like moderate-to-severe plaque psoriasis and psoriatic arthritis, one should be aware of potential side effects, such as upper respiratory infections, injection site reactions, and diarrhea.
- If you experience diarrhea from Ilumya, it's important to stay hydrated and discuss the issue with your doctor.
- Beyond these common side effects, less common adverse effects reported in clinical contexts for IL-23 inhibitors include headache, fatigue, nausea, and transient liver enzyme elevations or infections beyond the upper respiratory tract.
- Psoriasis affecting the scalp can cause temporary or permanent hair loss, but Ilumya itself was not reported to cause hair loss in clinical trials.
- It's crucial to consult the official Ilumya prescribing information from the FDA or the drug's label available on regulatory or manufacturer websites for a complete and authoritative list of less common side effects.
